A uncommon, inherited endocrine dysfunction whose normal therapies are steroids that introduce a variety of uncomfortable side effects now has a brand new FDA-approved remedy, a nonsteroidal Neurocrine Biosciences drug that might give the corporate a brand new blockbuster vendor. The FDA granted two approvals late Friday for the Neurocrine drug crinecerfont as a remedy for traditional congenital adrenal hyperplasia […]